Text Size

Targeted Intervention for Melanoma Prevention

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
American Cancer Society, Inc.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00394134
First received: October 27, 2006
Last updated: December 17, 2012
Last verified: December 2012
History of Changes
  Purpose

In this study, the researchers will conduct interviews with melanoma patients to describe the sun exposure and sun protection practices of patients and their children. The researchers will use the findings of this interview study to develop a salient intervention targeted to the needs of melanoma patients and their children. The researchers will evaluate the intervention in a randomized, controlled trial.

The specific aims of this study are:

  • To interview 210 melanoma patients with children 12 years of age or younger to describe patients' socio-cognitive and psychological factors, describe patients' and children's sun exposure and sun protection practices, and identify determinants of patients' and children's sun exposure and protective practices.
  • To develop a targeted behavioral intervention that is designed to increase patients' protective practices to reduce their children's sun exposure, increase patients' self-protective practices, decrease the sun exposure levels of patients and their children, and positively influence socio-cognitive and psychological determinants of child-centered and self-protective practices.
  • To conduct a randomized, controlled trial in a sample of 360 melanoma patients with children 12 years of age or younger to evaluate the targeted behavioral intervention consisting of print and video materials. The intervention will be assessed for its effects on: 1) child sun exposure and sun protection; 2) patients' protective practices to reduce their children's sun exposure; 3) patients' sun exposure and self-protective practices; and 4) patients' socio-cognitive and psychological factors that facilitate behavior change.

Condition Intervention
Melanoma
 Behavioral: Interview

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: A Targeted, Family-Focused Intervention for Melanoma Prevention

Resource links provided by NLM:

MedlinePlus related topics: Cancer Melanoma
U.S. FDA Resources

Further study details as provided by M.D. Anderson Cancer Center:

Primary Outcome Measures:
  • Patients'and Children's Sun Exposure and Protective Practices <Patient Interview Responses> [ Time Frame: Baseline Interview, 6 Month and 9 Month Interviews ] [ Designated as safety issue: No ]

Estimated Enrollment: 570
Study Start Date: April 2005
Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Interview
Interviews to describe the sun exposure and sun protection practices of patients and their children.
 Behavioral: Interview
Interviews to describe the sun exposure and sun protection practices of patients and their children.

Detailed Description:

Research is to learn about awareness, attitudes, and behaviors related to sun exposure, sun protection, skin examination, and other risk-reducing behaviors. The results of this study will be used to design an educational program on sun protection for persons who have had melanoma and their children.

The study will involve a telephone interview that will last about 45 minutes and will be scheduled at your convenience. Your participation in this study is completely voluntary and you may refuse to participate. Your decision about participating will not affect the care or services you or your family may receive at The University of Texas M. D. Anderson Cancer Center.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Melanoma patients are eligible if they:

  1. Were diagnosed with in situ, localized, or microscopic stage III melanoma after January 1, 1988.
  2. Are the parent of a child 12 years of age or younger and reside with the child.
  3. Provide informed consent.
  4. Are 18 years of age or older.
  5. Are able to speak, read, and write English.
  6. Meet all inclusion criteria.

Exclusion Criteria:

1. Melanoma patients are not eligible if they cannot provide informed consent.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00394134

Locations
United States, Texas
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
M.D. Anderson Cancer Center
American Cancer Society, Inc.
Investigators
Principal Investigator: Ellen R. Gritz, PhD M.D. Anderson Cancer Center
  More Information

Additional Information:
UT MDAnderson Cancer Center  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT00394134     History of Changes
Other Study ID Numbers: 2003-0901
Study First Received: October 27, 2006
Last Updated: December 17, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by M.D. Anderson Cancer Center:
Melanoma
Sun Exposure
Sun Protection
Interview

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
 Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas

ClinicalTrials.gov processed this record on May 19, 2013